World ME Day raises awareness of devastating symptom impacting millions post-COVID
To mark World ME Day on May 12, 2023, the World ME Alliance and its 22 member organizations are proud to announce the launch of a global awareness campaign addressing […]
Solve M.E. Ramsay Grant Program Updates Empower Patients
Through our Ramsay Research Grant Program, Solve M.E. invests in research studies into ME/CFS, Long Covid, and other post-infection diseases with a particular emphasis on engaging young investigators and propelling […]
Using a Heart Rate Monitor to Prevent Post-Exertional Malaise in ME/CFS & Long Covid
This article was first published on ProHealth.com and is reprinted on SolveME.org with permission of ProHealth and the author Suzan Jackson. Though originally written for individuals with ME/CFS managing PEM, members […]
Guest Blog: How People With Long Covid Can Qualify For Social Security Disability Benefits
Elizabeth Van Arsdall is a recent graduate of Colby College living in Boston and a native of Washington, D.C. Like so many others, Elizabeth has seen firsthand the effects of Covid […]
Meet the Members of Solve’s New Lived Experience Task Force (LET)
In December, we told you about a new Solve initiative, The Lived Experience Task Force (LET). LET was designed to serve as leadership partners with Solve M.E., a partnership based […]
Ask Congress to CARE!
We’re excited to announce our House and Senate asks for Solve M.E.’s Advocacy Week 2023! The two pieces of legislation are companion pieces to one another — we will be […]
Solve M.E. CEO Oved Amitay On Potential EBV Vaccine Candidate
Originally published by Solve M.E. CEO Oved Amitay in a LinkedIn post. Very encouraging to learn today that top experts from OPKO Health, Inc. and ModeX Therapeutics Inc team up with Merck to develop Epstein-BarrVirus Vaccine Candidate. […]
CDC Responds to Solve M.E. Comments on Draft Review of Diagnosis and Treatment of ME/CFS
In 2018, the Centers for Disease Control and Prevention (CDC) announced it was soliciting bids to create evidence-based treatment guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In 2019, the CDC […]
Kevin Timms, PhD, Joins Ramsay Researchers Class of 2022!
We’re excited to share that Kevin Timms, PhD, is joining our Ramsay Class of 2022! Solve’s Ramsay Research Grant Program attracts new scientists to the field of ME/CFS and Long […]
Watch now! “Long Covid: What Will it Take to Accelerate Therapeutic Progress?”
Solve M.E. and BIO co-hosted a timely and informative event examining the emerging research in Long Covid and the existing body of data in other post-infection diseases such as ME/CFS. […]
FDA to Host Patient-Focused Drug Development Public Meeting for Long Covid
The US Food and Drug Administration (FDA) is hosting a virtual public meeting on Patient-Focused Drug Development for Long Covid on Tuesday, April 25th, 2023, from 10 a.m. to 4:00 p.m. […]
Just released! FY23 Peer Reviewed Medical Research Program (PRMRP) Funding Opportunities for ME/CFS
At Solve M.E., our advocacy team is dedicated to opening new government funding avenues for ME/CFS, Long Covid, and post-infection disease research and care. Thanks in part to these efforts […]
